Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Antengene Presents Results from Three Investigational Programs at the 2024 SITC Annual Meeting
2024-11-06 09:08
Antengene to Present Results from Two Late-Stage Studies of Selinexor Signaling Potential Clinical Breakthrough at ASH 2024
2024-11-06 08:30
The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT 2024
2024-11-01 21:00
DX&VX Selected for Korea's First ARPA-H Project in 2024, Focusing on Room Temperature and Extra-Long-Term Vaccine Storage Technology
2024-11-01 21:00
CStone Announces MHRA Approval of Sugemalimab for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) in the UK
2024-10-31 13:00
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC
2024-10-31 12:34
Latest Updates of Viva Biotech's Portfolio Companies
2024-10-30 22:24
Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy
2024-10-30 15:00
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-10-29 20:30
GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024
2024-10-29 19:27
RemeGen Announces the Acceptance of the Marketing Application of Telitaccept for the Treatment of Myasthenia Gravis in China
2024-10-29 12:00
Innovent Announces Results of a Phase 2 Study of Picankibart (Anti-IL-23p19 Antibody) in Plaque Psoriasis, Showing Efficacy in Patients with Prior Inadequate Response to IL-17 Biologics
2024-10-29 07:57
/C O R R E C T I O N -- Seegene Inc./
2024-10-28 12:50
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
2024-10-25 20:30
HiConf Seoul 2024 successfully wraps up, sparks up discussions for future of food tech and international partnerships
2024-10-25 10:39
Innovation at the Forefront: Angel Yeast Shines at FHA 2024
2024-10-24 20:30
Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers
2024-10-24 10:00
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation
2024-10-24 08:08
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
2024-10-23 15:11
Australia's Healthcare Innovators in Stroke and Paediatric Care Honoured at 2024 Challenger Summit
2024-10-23 09:29
1
2
3
4
5
229